Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C10H16 |
| Molecular Weight | 136.234 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1CC=C(C)C=C1
InChI
InChIKey=OGLDWXZKYODSOB-UHFFFAOYSA-N
InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4-6,8,10H,7H2,1-3H3
| Molecular Formula | C10H16 |
| Molecular Weight | 136.234 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:24:04 GMT 2025
by
admin
on
Mon Mar 31 20:24:04 GMT 2025
|
| Record UNII |
49JV13XE39
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
JECFA EVALUATION |
ALPHA-PHELLANDRENE
Created by
admin on Mon Mar 31 20:24:04 GMT 2025 , Edited by admin on Mon Mar 31 20:24:04 GMT 2025
|
||
|
CFR |
21 CFR 172.515
Created by
admin on Mon Mar 31 20:24:04 GMT 2025 , Edited by admin on Mon Mar 31 20:24:04 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
202-792-5
Created by
admin on Mon Mar 31 20:24:04 GMT 2025 , Edited by admin on Mon Mar 31 20:24:04 GMT 2025
|
PRIMARY | |||
|
2530131
Created by
admin on Mon Mar 31 20:24:04 GMT 2025 , Edited by admin on Mon Mar 31 20:24:04 GMT 2025
|
PRIMARY | |||
|
49JV13XE39
Created by
admin on Mon Mar 31 20:24:04 GMT 2025 , Edited by admin on Mon Mar 31 20:24:04 GMT 2025
|
PRIMARY | |||
|
99-83-2
Created by
admin on Mon Mar 31 20:24:04 GMT 2025 , Edited by admin on Mon Mar 31 20:24:04 GMT 2025
|
PRIMARY | |||
|
1327
Created by
admin on Mon Mar 31 20:24:04 GMT 2025 , Edited by admin on Mon Mar 31 20:24:04 GMT 2025
|
PRIMARY | |||
|
C005403
Created by
admin on Mon Mar 31 20:24:04 GMT 2025 , Edited by admin on Mon Mar 31 20:24:04 GMT 2025
|
PRIMARY | |||
|
49JV13XE39
Created by
admin on Mon Mar 31 20:24:04 GMT 2025 , Edited by admin on Mon Mar 31 20:24:04 GMT 2025
|
PRIMARY | |||
|
m8585
Created by
admin on Mon Mar 31 20:24:04 GMT 2025 , Edited by admin on Mon Mar 31 20:24:04 GMT 2025
|
PRIMARY | Merck Index | ||
|
50035
Created by
admin on Mon Mar 31 20:24:04 GMT 2025 , Edited by admin on Mon Mar 31 20:24:04 GMT 2025
|
PRIMARY | |||
|
1130
Created by
admin on Mon Mar 31 20:24:04 GMT 2025 , Edited by admin on Mon Mar 31 20:24:04 GMT 2025
|
PRIMARY | |||
|
7460
Created by
admin on Mon Mar 31 20:24:04 GMT 2025 , Edited by admin on Mon Mar 31 20:24:04 GMT 2025
|
PRIMARY | |||
|
DTXSID4047593
Created by
admin on Mon Mar 31 20:24:04 GMT 2025 , Edited by admin on Mon Mar 31 20:24:04 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT MAY BE PRESENT |